Somewhat superficial overview about anaemia in intensive care patients whithout new aspects.>br> – Volker Kretschmer
Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions.
This preliminary (considering phase III studies have been completed or are underway) study in rats adds little to what has already been published on this issue in more elaborate animal models. While interesting, the study falls short of answering the true question: do hemoglobin solutions such as o-raffinose-crosslinked hemoglobin improve outcome in humans? – J.-F. […]
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
An excellent study about the use of AT III in septic patients. Carefully conducted study: the description in the method section is outstanding. It is noteworthy that this is the presentation of a study with negative results. – W. Dietrich.